Analysis of Excess Delaware Qualified Research Expenses and the Delaware Research and Development Tax Credit

I. Executive Summary: The Definition of Excess Delaware Qualified Research Expenses

I.A. Simple Statutory Definition

Excess Delaware Qualified Research Expenses (Excess DQREs) are the portion of a taxpayer’s current-year Delaware Qualified Research Expenses (QREs) that surpass the calculated Delaware Base Amount.1 This excess amount serves as the primary multiplier basis for determining the Delaware R&D Tax Credit under the standard calculation method codified in 30 Del. C. § 2070(a)(1).1

I.B. Statutory Context and Key Features

The concept of Excess DQREs is central to the Delaware R&D Tax Credit (Del. Code Ann. tit. 30, §§ 2070-2075) when a taxpayer elects the historical base method (Method A) for calculation.2 This method is designed to incentivize incremental growth in in-state research expenditures. The credit is calculated as a percentage of these expenses that exceed a moving historical average, known as the Delaware Base Amount.1

For general taxpayers, the credit is $10\%$ of the Excess DQREs; for qualifying small businesses, the rate is increased to $20\%$ of the Excess DQREs.1

This calculation method is one of two options available to taxpayers, who must make an annual, independent election regarding which method to use, regardless of the calculation method chosen for the federal R&D tax credit.3 The resulting credit is applied against the taxpayer’s qualified tax liability, and a defining characteristic of the Delaware incentive is that any unused credit is fully refundable to the taxpayer in the nature of a tax refund, providing valuable liquidity.1

II. Statutory Foundation and Framework of the Delaware R&D Tax Credit

II.A. Legal Basis and Integration with Federal Law (IRC § 41)

The authority for the Delaware Research and Development Tax Credit is codified in Title 30, Chapter 20, Subchapter VIII, specifically beginning with Section 2070.3 The state law utilizes federal definitions and methodology to determine whether expenditures qualify as research and development expenses.1 Any R&D activity conducted within Delaware that meets the federal requirements under Internal Revenue Code (IRC) § 41 automatically qualifies for the Delaware credit.2 This linkage ensures consistency in defining “qualified research,” thereby reducing the state-specific compliance burden regarding activity qualification.

II.B. The Annual Election of Calculation Methodology

Delaware permits taxpayers to elect one of two distinct methods for calculating the annual credit, and this decision is made annually.3 Crucially, the Delaware determination election is explicitly independent of the determination used by the taxpayer for their federal research and development tax credit.1 This independence allows corporations to optimize their state tax benefit separately, often electing the historical base method (Method A) in Delaware even if they use the Alternative Simplified Credit (ASC) federally, or vice versa.

II.C. Summary of Applicable Credit Rate Structure

The statutory framework provides four potential credit paths, differentiated based on whether the taxpayer qualifies as a small business and which method they elect.1

Under Method A, which utilizes the Excess DQREs calculation, the credit rates are:

1. General Rule: $10\%$ of the Excess DQREs over the Delaware Base Amount.1
2. Small Business Alternative: $20\%$ of the Excess DQREs over the Delaware Base Amount.1

Under Method B, which relies on the federal Alternative Simplified Credit (ASC) method (IRC § 41(c)(5)), the credit rates are applied to Delaware’s apportioned share of the federal credit:

1. General Rule: $50\%$ of Delaware’s apportioned share of the federal ASC.1
2. Small Business Alternative: $100\%$ of Delaware’s apportioned share of the federal ASC.1

This structure provides enhanced rates for small businesses, reinforcing the incentive for innovative startups and growth-stage companies within the state.

Table 1: Delaware R&D Tax Credit Rate Structure (30 Del. C. § 2070)

III. Deep Dive into Method A: Calculating the Excess Delaware Qualified Research Expenses

III.A. The Definitional Component: Excess DQREs (30 Del. C. § 2070(a)(1))

The calculation of the R&D credit under Method A relies entirely on identifying the magnitude of the research expenses that exceed a benchmark.3 This benchmark is the Delaware Base Amount. The formula for generating the Excess DQREs is straightforward:

$$Excess\;DQREs = Current\;DQREs – Final\;Delaware\;Base\;Amount$$

The complexity lies in the precise, multi-step calculation of the Final Delaware Base Amount, which serves as a metric for historical R&D investment within the state.2

III.B. Determining the Delaware Base Amount (The Four-Year Lookback)

The Base Amount calculation mandates the use of Delaware QREs and Delaware Gross Receipts from the four taxable years immediately preceding the current credit year (T-4 through T-1).2 This historical analysis is performed using the following steps, which mirror the instructions on Form 2070AC 6:

1. Fixed-Base Percentage (FBP) Determination: The FBP is calculated by taking the ratio of the taxpayer’s total Delaware QREs incurred during the four preceding years to the total Delaware Gross Receipts over those same four years.2 If a business has fewer than four years of history with both QREs and Gross Receipts, the Base Amount calculation utilizes the available years; if no history exists, the FBP is zero.2
2. Average Annual Gross Receipts (AAGR): The AAGR is the arithmetic mean of the Delaware Gross Receipts over the four-year lookback period (T-4 through T-1).2
3. Preliminary Base Amount Calculation: The Preliminary Base Amount is derived by multiplying the FBP by the AAGR.6 This represents the historical investment level that must be exceeded to generate incremental, creditable expenses.

III.C. The Mandatory 50% Current-Year QRE Floor Limitation

The determination of the Delaware Base Amount is subject to a statutory floor intended to ensure that the credit is only awarded for truly incremental research investment.2 The Delaware Base Amount used in the final subtraction must be the greater of the calculated Preliminary Base Amount (FBP $\times$ AAGR) or $50\%$ of the current year’s total Delaware QREs.2

This $50\%$ floor acts as a significant limiting factor. Even if a company’s historical fixed-base percentage calculation yields a Base Amount far below the current year’s QREs, the Base Amount will be artificially inflated up to $50\%$ of the current QREs if the calculated Preliminary Base Amount is lower.6

III.D. Final Determination of Excess DQREs

Once the Final Delaware Base Amount (subject to the $50\%$ floor) is established, it is subtracted from the current year’s Delaware QREs (Line 6 minus Line 5, subject to Line 8 limit, on Form 2070AC).6 If the result of this subtraction is zero or negative, the taxpayer has no Excess DQREs, and thus no credit under Method A for the taxable year.6

III.E. The Financial Implication of the Effective Credit Rate Cap

The application of the $50\%$ current-year QRE floor has a direct, material effect on the maximum benefit derived from Method A. Because the Base Amount is mandated to consume at least $50\%$ of the current QREs, the amount eligible to be classified as Excess DQREs is inherently capped at $50\%$ of the total current QREs.

Consequently, the nominal credit rates of $10\%$ (for general taxpayers) and $20\%$ (for small businesses) are functionally capped when viewed against the total current-year QREs:

• Maximum effective credit rate for general taxpayers: $10\%$ of ($50\%$ of total QREs) = $5\%$ of total QREs.
• Maximum effective credit rate for small businesses: $20\%$ of ($50\%$ of total QREs) = $10\%$ of total QREs.

Corporate tax planners must recognize this floor, as it significantly moderates the potential cash benefit available under Method A and necessitates substantial year-over-year growth in Delaware QREs (well above $50\%$ of the historical baseline) to fully utilize the stated nominal credit rate. If R&D expenditures are simply maintained from one year to the next, the $50\%$ floor will likely apply, resulting in a significantly reduced credit amount relative to the total expenditure.

IV. Small Business Enhancements and Dynamic Thresholds

IV.A. Small Business Definition and the IRC Linkage

Delaware provides robust enhancements to the R&D credit for small businesses. The definition of a “small business” for the purpose of 30 Del. C. § 2070 is a taxpayer whose average annual gross receipts do not exceed the applicable threshold of $\$20,000,000$.1 This determination of average annual gross receipts must follow the methodology established in IRC § 41(c)(1)(B).1

A key requirement is that taxpayers electing to use the alternative calculation for small businesses must strictly conform to this definition, irrespective of the method they use to calculate their federal R&D tax credit.1

IV.B. Statutory Adjustment Factor (30 Del. C. § 515)

While the statutory threshold is initially set at $\$20,000,000$, the legal framework dictates that this amount is subject to mandatory annual adjustment.1 Title 30, Section 515 of the Delaware Code requires the Department of Finance to calculate a threshold adjustment factor annually, presenting this adjustment to the Delaware Economic and Financial Advisory Council by October 25th each year.8

This statutory requirement means the $\$20,000,000$ figure should not be relied upon as a static cap. Businesses whose gross receipts hover near this level must annually verify the officially adjusted threshold published by the Delaware Division of Revenue (DOR) to confirm their small business status for the current taxable year. Failure to track this dynamic threshold could lead a company to incorrectly claim the higher $20\%$ or $100\%$ rate.

IV.C. Application of Enhanced Rates (20% and 100%)

The designation as a small business effectively doubles the potential state incentive recovery under both calculation methodologies.1

• Under Method A, the credit rate applied to Excess DQREs increases from $10\%$ to $20\%$.3
• Under Method B, the state’s percentage of the apportioned federal ASC increases from $50\%$ to $100\%$.3

This targeted incentive structure makes the credit exceptionally competitive for high-growth, early-stage companies that meet the gross receipts criteria.

V. Division of Revenue Guidance and Administrative Compliance (Form 2070AC)

V.A. Mandatory Application and Timeline

Claiming the Delaware R&D tax credit is not automatic; it requires pre-approval from the Delaware Division of Revenue (DOR).6 The necessary administrative vehicle is Form 2070AC, the “Application and Computation Schedule for Claiming Delaware Research and Development Tax Credits”.6 The statutory deadline for submission is critical: the completed Form 2070AC must be submitted to the DOR on or before September 15th after the end of the taxable year during which the qualified R&D expenses were incurred.6

V.B. Required Federal Documentation

To substantiate the claim, the taxpayer must attach a copy of the Federal Form 6765, Credit for Increasing Research Activities, to the Delaware application.6 If the Delaware corporate applicant files as part of a federal consolidated corporate income tax return, they are required to attach a proforma Federal Form 6765 specifically detailing the applicant’s expenses and federal calculation.6 This ensures that the DOR can verify the underlying QREs meet the IRC § 41 standards, reinforcing the state’s reliance on federal definitions.2

V.C. Line-by-Line Mapping of Form 2070AC (Method A)

The instructions provided by the DOR on Form 2070AC clarify the precise steps necessary to calculate the Excess DQREs and the final credit amount under Method A. These steps directly implement the statutory requirements for the Base Amount calculation, including the mandatory floor.6

Table 2: DOR Form 2070AC Method A Computation Mapping

Line 9 of the application schedule is the critical culmination of the Excess DQRE calculation. By forcing the taxpayer to take the smaller of the raw excess (Line 7) or $50\%$ of the current QREs (Line 8), the DOR ensures that the $50\%$ floor discussed in Section III.C is mathematically enforced, restricting the size of the Excess DQREs used to calculate the final credit.6

VI. Contextual Analysis: Calculation Method B (Apportioned Federal ASC)

VI.A. Overview and Use of IRC § 41(c)(5)

Method B provides an alternative calculation path that circumvents the complex historical record-keeping and four-year base calculation required by Method A.3 This method is elective and relies on the taxpayer having computed their federal research credit using the Alternative Simplified Credit (ASC) method under IRC § 41(c)(5).1

VI.B. Detailed Apportionment Mechanism

Method B does not rely on Excess DQREs; instead, it uses the taxpayer’s calculated federal ASC as its starting point. This federal credit amount must then be apportioned specifically to Delaware based on the geographic distribution of the research expenses.1

Delaware’s apportioned share of the federal credit is calculated by multiplying the federal ASC claimed under IRC § 41(c)(5) by a ratio.1 This ratio is the fraction of Delaware QREs for the taxable year divided by the taxpayer’s total QREs for the taxable year, regardless of where they were incurred.3

$$Delaware\;Apportioned\;Share = Federal\;ASC \times \frac{Delaware\;QREs}{Total\;QREs}$$

The final credit under Method B is then $50\%$ of this Delaware Apportioned Share (or $100\%$ for small businesses).1

VI.C. Strategic Trade-Offs Between Methods A and B

The choice between Method A (Excess DQREs) and Method B (Apportioned ASC) is a strategic annual decision. Method A typically yields a higher credit only when a company exhibits substantial, sustained year-over-year growth in Delaware QREs, allowing the growth to significantly outpace the calculated Base Amount (FBP $\times$ AAGR) and exceed the $50\%$ floor.2

Conversely, Method B is often advantageous for:

1. Companies with limited operating history, where the calculation of the historical four-year FBP required for Method A is complex or yields a low benefit.2
2. Companies with fluctuating QREs, where the ASC mechanism provides a more stable, percentage-based credit relative to a three-year average base.
3. Small businesses, where the $100\%$ rate on the apportioned ASC offers a potentially greater recovery than the $20\%$ rate applied to the often-constrained Excess DQREs under Method A.

VII. Credit Utilization, Refundability, and Aggregate Limitations

VII.A. The Refundability Feature: Immediate Liquidity

A critical component of the Delaware R&D tax credit is its status as a fully refundable incentive.2 The statute explicitly states that the research and development tax credit shall first be applied against the taxpayer’s qualified tax liability.1 However, if the taxpayer cannot use the entire amount of the approved credit against their liability, the unused portion is not carried forward (as is standard for many federal credits, such as the 20-year carryforward rule 10), but rather paid to the taxpayer in the nature of a tax refund.1

This immediate refundability is a powerful economic tool, particularly for technology and biotechnology startups that are pre-revenue or pre-profit and therefore have little to no state corporate income tax liability against which to apply a credit. The refund transforms the credit from a future tax reduction into non-dilutive working capital, directly supporting R&D cash flow.

VII.B. The Annual Aggregate Cap and Proration Risk

While the credit is fully refundable, its availability is constrained by an annual aggregate state cap. The total amount of R&D tax credits approved by the Director of the Division of Revenue for all applicants combined shall not exceed $\$5,000,000$ in any fiscal year.6

This $\$5,000,000$ limitation introduces an element of execution risk for the taxpayer. If the total eligible credits applied for by all businesses statewide exceeds the $\$5$ million cap, the credit received by each applicant will be subject to proration.6

The prorated credit is determined by the following formula 6:

$$Prorated\;Credit = \$5,000,000 \times \frac{Eligible\;R\&D\;Tax\;Applied\;For\;by\;Applicant}{Total\;Eligible\;R\&D\;Tax\;Credits\;Applied\;For\;by\;All\;Applicants}$$

Taxpayers must understand that the maximum benefit calculated on Form 2070AC is provisional until the DOR determines the total claims filed statewide by the September 15th deadline. This necessitates timely filing, as the Proration risk must be factored into the financial modeling and cash flow forecasting of companies relying on this incentive.

VII.C. Credit Allocation for Flow-Through Entities

For flow-through entities such as S Corporations and Partnerships, the approved credit is not retained at the entity level but must be allocated to the owners.6

• For S Corporations, the approved Delaware R&D Credit is multiplied by the percentage of stock owned by each shareholder and entered on Line 10(b) of Form 700 (Delaware Income Tax Credit Schedule).6
• For Partnerships, the credit is multiplied by the percentage ownership of each partner and entered on Line 10(c) of Form 700.6
• For Individuals and Sole Proprietors, the full credit is reported on Form 700, Line 10(d).6

VIII. Numerical Case Study: Calculation of Excess Delaware QREs

This example illustrates the calculation of Excess Delaware Qualified Research Expenses (Excess DQREs) for a standard taxpayer utilizing Method A (10% rate) and demonstrates the constraining effect of the mandatory 50% QRE floor.

VIII.A. Base Period Data Establishment

Assume a Delaware company, “Delaware Innovators, Inc.” (DII), is a general taxpayer (average gross receipts $>\$20,000,000$) preparing its tax return for the current credit year (T).

Table 3: Base Period Data for Excess DQRE Calculation

VIII.B. Scenario A: General Taxpayer (10% Rate) Calculation

Current Year (T) Data:

• Current Year Delaware QREs (Line 6): $\$1,000,000$

Step 1: Calculate the Fixed-Base Percentage (FBP)

$$FBP (Line\;3) = \frac{Total\;DQREs\;(T-4\;to\;T-1)}{Total\;DG\;(T-4\;to\;T-1)} = \frac{\$2,200,000}{\$44,000,000} = 0.05$$

The FBP is $5.00\%$.

Step 2: Calculate the Preliminary Base Amount

$$Preliminary\;Base\;Amount (Line\;5) = FBP \times Average\;DG = 0.05 \times \$11,000,000 = \$550,000$$

Step 3: Calculate the Raw Excess over Preliminary Base

$$Raw\;Excess (Line\;7) = Current\;DQREs – Preliminary\;Base\;Amount$$

$$Raw\;Excess = \$1,000,000 – \$550,000 = \$450,000$$

Step 4: Apply the Mandatory 50% QRE Floor Limitation

The Base Amount must ensure that Excess DQREs (Line 9) does not exceed $50\%$ of the current QREs.

$$50\%\;QRE\;Floor\;Limit (Line\;8) = Current\;DQREs \times 50\%$$

$$Limit = \$1,000,000 \times 0.50 = \$500,000$$

Step 5: Determine the Final Excess DQREs

The Final Excess DQREs (Line 9) is the smaller of the Raw Excess (Line 7: $\$450,000$) or the $50\%$ Limit (Line 8: $\$500,000$).6

In this scenario, the Raw Excess is smaller:

$$Final\;Excess\;DQREs (Line\;9) = \$450,000$$

Step 6: Calculate the Final Credit (General Taxpayer Rate: 10%)

$$Delaware\;R\&D\;Credit (Line\;10) = Final\;Excess\;DQREs \times 10\%$$

$$Credit = \$450,000 \times 0.10 = \$45,000$$

VIII.C. Scenario B: Small Business (20% Rate) Calculation

If DII qualified as a small business (e.g., if its Average DG was below the adjusted statutory threshold), the Excess DQREs calculation remains identical, resulting in a Final Excess DQREs amount of $\$450,000$.

The small business benefit is applied solely in the final step:

$$Delaware\;R\&D\;Credit = Final\;Excess\;DQREs \times 20\%$$

$$Credit = \$450,000 \times 0.20 = \$90,000$$

This numerical example demonstrates that while the base calculation methodology is highly complex, the benefit hinges on the generation of Excess DQREs and the application of the appropriate statutory rate, which doubles for small businesses (from $\$45,000$ to $\$90,000$ in this comparison).

IX. Conclusion and Strategic Recommendations

The Delaware Research and Development Tax Credit, calculated primarily based on Excess Delaware Qualified Research Expenses (Method A), provides one of the most powerful and liquid state incentives for innovation. Its mechanism is rooted in rewarding incremental increases in qualified research activities above a defined historical base, subject to complex limiting constraints designed to manage state exposure.

The determination of Excess DQREs requires meticulous compliance with 30 Del. C. § 2070, necessitating accurate tracking of Delaware QREs and Gross Receipts over a four-year lookback period. The most critical constraint on the credit base is the statutory minimum Base Amount, which effectively limits Excess DQREs to $50\%$ of the current year’s QREs, capping the maximum effective credit recovery at $5\%$ (general rate) or $10\%$ (small business rate) of total QREs.

Strategic Recommendations

1. Prioritize Application Timeline: Given the mandatory $\$5,000,000$ annual aggregate cap for all applicants, the September 15th filing deadline for Form 2070AC is paramount.6 Timely submission is necessary to ensure the claim is included in the pool before the proration calculation, thereby mitigating the financial uncertainty associated with the cap.
2. Evaluate Method Election Annually: Taxpayers should conduct a robust annual analysis comparing the results of Method A (Excess DQREs) versus Method B (Apportioned Federal ASC).3 Newer or rapidly expanding companies may benefit more from Method B due to its avoidance of the complex historical Base Amount calculation and the possibility of utilizing the $100\%$ rate if they qualify as a small business.
3. Hedge Against Threshold Volatility: Taxpayers approaching the $\$20,000,000$ gross receipts threshold for small business status must not rely on the static statutory figure.1 They must proactively review the annual adjustment factor calculated and published by the Department of Finance under 30 Del. C. § 515 to confirm eligibility for the enhanced $20\%$ or $100\%$ rates each tax year.1
4. Leverage Refundability for Working Capital: The defining feature of the Delaware credit is its full refundability.1 Companies, especially those in early stages with high R&D costs and minimal tax liability, should strategically view the credit as a direct source of non-dilutive financing rather than merely a future tax reduction tool. The compliance process should be managed to maximize cash recovery.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/